That is essential, since the method a protein in the body folds determines if a pharmaceutical will be able to bind to that protein and work. Simply put, we need to understand how these proteins fold if we want a drug to work. Historically, this has been a trial-and-error procedure (bleeding edge). Now, Alpha, Fold can predict protein folding with 92. 4% accuracy. That's going to make it much easier to create drugs that do what they're designed to do. This was a development practically nobody saw. However it's going to have extensive implications for curing disease. I forecast that Alpha, Fold will be 98% accurate by the end of 2021.
And, naturally, there will be plenty of financial investment chances in this area, too. Moving topics It's going to be a great year for bitcoin. I'm bullish on it in 2021 (biotech stocks jeff brown). That stated, I still believe bitcoin will continue to be unpredictable. We're close to all-time highs. I would not be amazed if it pulled back possibly substantially before going higher - biotech stocks. I have actually been covering bitcoin for a very long time now. Among the first research reports I ever released was on bitcoin. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
However at the time of that initial suggestion, I titled my report "What's the Big Offer With Bitcoin?" That reveals you where the discussion was at the time. We were primarily educating readers. But that's not the big question any longer. Now we're seeing institutional cash lastly take an interest in bitcoin. Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some small, specific niche enterprise. Mass, Mutual is a trusted 170-year-old institution. So think of that. In 5 years, we went from informing readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake.
And that's a big factor I'm bullish on it this year. jeff brown predictions 2021. Regards, Jeff Brown, Editor, The Bleeding Edge I have a perk prediction 2020 was a record year for IPOs. 552 U.S. companies went public the most in more than 20 years. These companies raised an overall of $172 billion. That's an all-time high beating the previous annual record by 43%. I forecast 2021 will be another record year in IPOs. There are a lot of terrific personal companies on the edge of striking the general public markets And I've been working on a brand-new method for you to invest even before these business go public.
This opportunity has been building over the last few years. I can't wait to tell you all about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Event to learn all the information. Go right here to schedule your area free of charge.
Emma Walsh here, handling editor of the Diary. Routine Journal readers know that tech isn't our usual beat (second wave). And when it concerns tech investing, we leave it to the specialists. The good news is, we have several such professionals in our Rolodex. Our associate Jeff Brown will recognize to our longtime readers. He is one of the most accomplished tech investing specialists we understand (bleeding edge). In truth, he had a number of triple-digit returns in his Brownstone Research study portfolios last year. Here's what Jeff believes the tech sector will bring us in 2021 Each year, I like to take a look at the huge picture and anticipate what's simply around the corner.
That consists of things like 5G networks, biotech, expert system, and much more. These trends are experiencing rapid growth and producing unbelievable chances for investors. I wish to make sure all our readers are gotten ready for what's next. And with that in mind, let me draw the picture of what I see being available in the next 12 months Our new 5G (fifth-generation) cordless networks are a subject I've been covering for years now. artificial intelligence. But in spite of what numerous readers might think, this is a pattern that's just beginning. Although the COVID-19 pandemic interrupted supply chains last year, an impressive 250 million 5G-enabled gadgets were still offered.
And all of this ultimately resulted in Apple delaying the release of the 5G-enabled i, Phone 12 by two months (longtime readers). Losing 2 months of manufacturing and sales truly impacts the number of 5G devices are sold in the calendar year. When you think about all of that, selling 250 million systems is amazing. More importantly, the hold-ups triggered by the pandemic developed a lots of suppressed need. Which demand is now going to be pressed into 2021. In truth, I forecast that more than 500 million 5G devices will be shipped in 2021 - democratic republic. Which's not my only 5G prediction When I have actually discussed 5G in the past, I have actually explained its three different phases.
In Stage 2, 5G gadgets go on sale. 5G phones and other products begin to reach consumers. And in Phase Three, 5G services start to be used (united states). That's when we start to see applications running on 5G networks. Think about things like enormous multiplayer video games over a mobile phone. That's not possible with 4G. It will be with 5G. And my 2nd 5G forecast for 2021 is that we will begin Phase Three by this summer. This begins something of a virtuous cycle: The majority of people do not really appreciate the innovation. But they will care if there are interesting applications that can only be accessed with a 5G phone.
That causes more 5G apps being developed. In reality, 5G is going to open up a suite of unbelievable applications: self-driving cars, the Web of Things, robotic surgical treatment, and more. All of these technologies require 5G. The financial investment opportunities moving forward will be huge. Stepping far from 5G, the next important innovation I visualize in 2021 is CRISPR hereditary editing. CRISPR represents "clustered routinely interspaced short palindromic repeat." It's a mouthful. But it is among the most interesting developments in biotechnology. At a high level, CRISPR is an innovation that can edit our genetic makeup as if it were software.
The program can crash or not work properly. CRISPR utilizes a comparable idea but with our hereditary code. "Typos" in our genome can cause disease. CRISPR can remedy these "typos." For many years, CRISPR was mostly a specific niche innovation that wasn't well comprehended. And during that time, there were really just 3 companies operating in this space. But things are changing. CRISPR is no longer simply theoretical. We're seeing real results. We're treating diseases and seeing that this innovation simply works. And as a result, a "2nd crop" of early-stage CRISPR companies is going public and providing unbelievable returns. This whole industry is successfully a greenfield chance.
There's space for lots of business to exist in this space. black sea. And there will be more. That's my forecast for CRISPR in 2021. I forecast that two or 3 more hereditary modifying companies will hold their IPOs. Sticking to biotechnology, we are seeing remarkable things occurring at the convergence of biotech and expert system (AI). Google's AI subsidiary, Deep, Mind, simply revealed at the end of 2020 that its newest Alpha, Fold software application can properly forecast the folding of a protein based solely on its amino acid sequence with 92. 4% precision. That is essential because the way a protein in the human body folds identifies if a pharmaceutical will be able to bind to that protein and work.
Historically, this has actually been an experimental process. And now, Alpha, Fold can anticipate protein folding with 92. 4% precision. That's going to make it much easier to create drugs that do what they're designed to do. And here's my next forecast. I predict that Alpha, Fold will be 98% precise by the end of 2021. And we will see not just one but several drug therapies produced using this innovation. This was one of those developments that almost no one saw. However it's going to have profound ramifications for treating illness. And, obviously, there will be plenty of financial investment chances in this area, too.
It's going to be a good year for bitcoin. I'm bullish on it in 2021. That stated, I still think bitcoin will continue to be unpredictable. We're close to all-time highs. I wouldn't be surprised if it drew back maybe significantly before going greater. I've been covering bitcoin for a long period of time now. Among the very first research reports I ever released was on bitcoin - jeff brown predictions for 2021. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ return on financial investment for anybody who followed my recommendation. But at the time of that initial suggestion, I entitled my report, "What's the Big Deal With Bitcoin?" That reveals you where the conversation was at the time.
However no one is asking that question any longer. Now, we're seeing institutional money finally taking an interest in bitcoin. The huge news was that Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some little, specific niche enterprise. the legacy report prediction. Mass, Mutual is a 150-year-old institution. So believe about that. In 5 years, we went from informing readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. And that's a big reason that I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have one more perk forecast In 2021, we're going to have another record year in IPOs. One website reports that Jeff Brown is worth about $27. 5 million and claims the information is up to date as of February 2021, however we could not independently validate this claim. Provided Jeff Brown's past, he likely has a considerable net worth, however we can't hammer down an accurate figure at this moment. Brown is best known for his sage-like ability to pick winning innovation stocks. He spent more than 25 years looking into innovation business like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's comprehensive experience gives him an outstanding viewpoint on the market. He's always on the hunt for brand-new chances, and he shares much of his best choices in the Near Future Report.
That's full marks, but it's not absurdly reasoned. Brown has an outstanding reputation as a stock-picker, and he effectively anticipated some of the most significant economic events of the previous 20 years. Although he does not appear to launch his picks to the public, the service's success is a direct indication of Brown's stock-picking expertise. Nobody on Wall Street gets it ideal whenever, but Jeff Brown's precise forecasts have actually made him legions of devoted followers. That says a lot about his ability. The Near Future Report is published by Brownstone Research study, a popular financial research publisher. Brownstone Research study provides numerous research study services with a wide array of expertises - jeff brown.
The company is likewise affiliated with Bonner & Partners, another well-respected research publisher - brownstone research. On its site, Brownstone says its mission is to provide retail investors with professional-grade research: "For too long, the finest investment research has not been available to private financiers. It has been usually booked for investment banks, hedge funds, personal equity, and high-net-worth customers. jeff brown 2021 predictions. The objective of Brownstone Research is to make that type of exclusive research available to any financiers wanting to get an edge in the markets. The goal is easy to provide special and rewarding financial investment research found nowhere else." -Brownstone Research study site excerpt from the Jeff Brown is the creator of Brownstone Research study, and he likewise serves as the company's Chief Investment Analyst.
With Brown guiding the ship, Brownstone Research is a powerhouse publisher with lots to offer its clients. After years of constant success at the helm of top-tier companies like Tesla and Space, X, Elon Musk is a home name throughout most of America. If you understand even a bit about the marketplace, you know that he has a track record as a King Midas of sorts. brownstone research stock. Everything he touches relies on gold! Jeff is well conscious of Elon Musk's executive prowess, so he constantly has an eye out for the Silicon Valley rock star's next move. This time, Jeff has an early lead on Elon's next huge project.
In fact, Brown believes S.A.V. democratic republic. might be "the most significant pattern of the 2020s, and he's not alone. Inspect out these quotes from other widely known S.A.V. bulls: Elon's next big act will be marrying two cutting-edge technologies: synthetic intelligence and electric vehicles. Musk hopes the combination will help him establish the first fully-autonomous, self-driving cars and trucks ever. It's absolutely nothing except the automotive market's Holy Grail. As you know, electrical cars and self-driving automobile stocks have actually been big this year, however the Wall Street machine has actually been huge on hype without much concrete result. Regardless of a drastic increase in competition over the previous few years, Brown still believes Musk has the finest chance of putting it all together.
tech might be the magic string that ties it all together. S.A.V. stands for Shared Autonomous Automobile, and it might be the future of transportation. Essentially, this innovation would enable you to rent your automobile as a self-governing, self-driving taxi when you're not utilizing it. You just leave the cars and truck and press a button on an app that tells the cars and truck to "sign up with the fleet." Next thing you understand, you're relaxing on your sofa while your cars and truck shuttles ride-sharers around town. Best of all, you get to keep a significant chunk of the profits. It sounds outrageous, but it could be closed than you believe.